Yahoo Finance talks to Axovant CEO Vivek Ramaswamy about how he turned a $5 million shelved drug into $3 billion and a potential Alzheimer’s breakthrough.
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
Filed Under: Drug Discovery
